Novartis Says Vanrafia Drug Slows Kidney Function Decline
Novartis(US:NVS) WSJ·2026-02-13 06:57The pharma major said that phase 3 trials showed Vanrafia slowed the decline in kidney function for adults with progressive autoimmune kidney disease, IgA nephropathy. ...